Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.19 M1.76 M2.13 M2.03 M2.25 M 8.17 M Research & development ————— — Operating income 10.12 M11.86 M-11.45 M14.03 M12.51 M 26.94 M Non-Operating Income, Total 136 K148 K-11.6 M101 K152 K -11.2 M Interest expense, net of interest capitalized 6.94 M6.61 M6.61 M7.69 M6.14 M 27.04 M Non-Operating Income, excl. Interest Expenses -6.8 M-6.46 M-18.21 M-7.58 M-5.99 M -38.24 M Unusual income/expense ————— — Pretax income 2.34 M4.71 M-7.02 M5.27 M4.58 M 7.54 M Equity in earnings ————— — Taxes 427 K766 K-1.32 M528 K714 K 684 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.91 M3.95 M-5.7 M4.74 M3.87 M 6.86 M Discontinued operations ————— — Net income 1.91 M3.95 M-5.7 M4.74 M3.87 M 6.86 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.91 M3.95 M-5.7 M4.74 M3.87 M 6.86 M Basic earnings per share (Basic EPS) 0.370.79-1.140.950.77 1.37 Diluted earnings per share (Diluted EPS) 0.350.74-1.070.90.73 1.3 Average basic shares outstanding 5.13 M5.02 M4.99 M5.04 M5.05 M — Diluted shares outstanding 5.47 M5.33 M5.32 M5.31 M5.32 M — EBITDA 3.89 M5.96 M-17.46 M7.45 M7.02 M 2.98 M EBIT 3.43 M5.51 M-17.92 M6.99 M6.58 M 1.16 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 442 K452 K455 K461 K445 K 1.81 M